Background-Myocardial infarction leads to cardiac remodeling and development of heart failure. Insufficient myocardial capillary density after myocardial infarction has been identified as a critical event in this process, although the underlying mechanisms of cardiac angiogenesis are mechanistically not well understood. Methods and Results-Here, we show that the small noncoding RNA microRNA-24 (miR-24) is enriched in cardiac endothelial cells and considerably upregulated after cardiac ischemia. MiR-24 induces endothelial cell apoptosis, abolishes endothelial capillary network formation on Matrigel, and inhibits cell sprouting from endothelial spheroids. These effects are mediated through targeting of the endothelium-enriched transcription factor GATA2 and the p21-activated kinase PAK4, which were identified by bioinformatic predictions and validated by luciferase gene reporter assays. Respective downstream signaling cascades involving phosphorylated BAD (Bcl-XL/Bcl-2-associated death promoter) and Sirtuin1 were identified by transcriptome, protein arrays, and chromatin immunoprecipitation analyses. Overexpression of miR-24 or silencing of its targets significantly impaired angiogenesis in zebrafish embryos. Blocking of endothelial miR-24 limited myocardial infarct size of mice via prevention of endothelial apoptosis and enhancement of vascularity, which led to preserved cardiac function and survival.
Clinical Perspective on p 730
MicroRNAs (miRNAs) are endogenous small noncoding RNA molecules that regulate a substantial fraction of the genome by binding to the 3Ј untranslated region (3ЈUTR) of frequently coordinately acting target messenger RNAs. 5 MiRNAs have been identified as valuable therapeutic targets in a variety of diseases, including cardiovascular disease. 6 -12 Inhibition of miRNA processing by genetic knockdown of Dicer expression impairs endothelial functions and angiogenesis. [13] [14] [15] Certain miRNAs are important regulators of endothelial function, especially angiogenesis. 7, [13] [14] [15] [16] [17] A subset of miRNAs is regulated by tissue oxygen levels, and miR-24 is activated by hypoxic conditions via the hypoxia-inducible factor 1 (HIF-1). 18 Although miR-24 is expressed in a variety of organs, 19 it is enriched in endothelial cells, 20 but its role in the cardiovascular system remains basically uncertain. Here, we show that miR-24 acts as a critical regulator of endothelial cell apoptosis and angiogenesis and is suitable for therapeutic intervention in the setting of ischemic heart disease.
Methods
miRNA/RNA Isolation, miRNA Reverse Transcription-Polymerase Chain Reaction, and Global Transcriptome Analysis RNA isolation was performed with TRIzol reagent (Invitrogen) or the miRVana miRNA Isolation Kit (Ambion) according to the manufacturer's instructions. For detection of miRNAs in samples, different TaqMan miRNA assays (Applied Biosystems) were applied (online-only Data Supplement Table I ). The small RNA molecule U6 small nuclear (Rnu6 -2) was amplified as a control. Reverse transcription-polymerase chain reaction analysis was performed in an ICycler (Bio-Rad). To assess RNA integrity for downstream array analysis, total RNA was subjected to capillary chromatography in an Agilent bioanalyzer 2100. Gene array analysis was performed with the Affymetrix GeneChip system according to the manufacturer's instructions and with Human Gene 1.0ST arrays (Affymetrix Systems). Further microarray analyses and data handling were performed as described previously. 21 
Transfection Assays
Transient liposomal transfection of small inhibitory RNAs (siRNAs) or miRNAs was performed according to the manufacturers' instructions. Briefly, cells were split 1 day before transfection to reach 60% to 70% confluence on the day of transfection. Specific siRNAs/ miRNAs and control siRNA/miRNA and Lipofectamine 2000 (Invitrogen) were mixed separately and incubated for 5 minutes with Opti-MEM I media (Invitrogen). Complexes were added together and incubated for 20 minutes. Media were changed to antibiotic-free media before the addition of liposomal siRNA complexes (final concentration 150 nmol/L for siRNA and 100 nmol/L for miRNAs). Cells were incubated for 4 hours before the media were changed to fresh media. Silencing of proteins or miRNA targets was monitored for 48 hours (siRNA) or 72 hours (miRNAs) after transfection by Western blot analysis. Specific details about the siRNAs and miRNAs used are given in Table II in the online-only Data Supplement.
Apoptosis Detection
Apoptosis was measured with the Annexin-V-Fluos kit from Roche Diagnostics (Penzberg, Germany) according to the manufacturer's instructions and as described previously. 6 Detection of apoptosis was either done by fluorescent-activated cell sorter analysis on a FACSCalibur (BD Biosciences) or by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays.
Western Blotting and ELISA
Western blot analysis was performed with 10 to 40 g of total protein. Protein was blotted onto polyvinylidene fluoride membrane in Mini Trans-Blot electrophoretic transfer cell (Bio-Rad). Afterward, different antigens were detected by appropriate antibodies (online-only Data Supplement Table III ). For phosphorylated Bcl-XL/Bcl-2-associated death promoter (phospho-BAD; Ser112) detection in cell culture samples, we applied a PathScan phospho-BAD (Ser112) sandwich ELISA kit (No. 7182; Cell Signaling) according to the manufacturer's instructions. Phospho-BAD levels were related to total BAD expression levels as obtained by Western blotting.
Analysis of Capillary and Arteriolar Density
Analyses of capillary and arteriolar density were performed in transverse sections of the periinfarct zone and the remote zone from left ventricles 14 days after MI. Capillary and arteriolar densities were evaluated after fluorescent immunohistochemical staining for platelet and endothelial cell adhesion molecule-1 (PECAM-1; endothelial marker) or ␣-smooth muscle actin (Acta2; smooth muscle cells) with antibodies listed in online-only Data Supplement Table  III . Arterioles were recognized as vessels with 1 or more continuous layer of Acta2 ϩ vascular smooth muscle cells. The number of capillaries and arterioles per square millimeter was counted in a blinded fashion.
Tube Formation and Spheroid Formation Assay
Transfection or transduction of cultured cells was performed as mentioned previously. Then, cells were harvested and 15 000 cells were seeded on top of Matrigel-coated chamber slides (BD). After 6 to 8 hours and 24 hours, pictures were taken on a Zeiss AxioVision microscope (Jena, Germany). In selected experiments, a pan-caspase inhibitor (caspase 3 inhibitor I; Calbiochem; 100 mol/L, 72 hours) was used. For spheroid formation, miRNA-transfected human umbilical vein endothelial cells were trypsinized and collected in EBM-2 medium containing FCS and 20% Methocel (Sigma-Aldrich). 500 cells in 100 l of medium were plated per well in a 96-well plate (U-shaped bottom) and cultivated overnight at 37°C, 5% CO 2 . The next day, spheroid formation was visualized by microscopy on a Nikon ECLIPSE Ti at 10ϫ or 20ϫ magnification. Spheroids were harvested at 200g and resuspended in a mixture of 80% Methocel and 20% FCS. Next, 50 spheroids per well were distributed in a 24-well plate by taking 500 L of spheroid suspension together with 500 L of collagen-containing matrix (DMEM, collagen solution, and NaOH). After 30 minutes' incubation at 37°C, 100 L of EBM-2 medium supplemented with 40% FCS and basic fibroblast growth factor (30 ng/mL) was given on top of casted gels. Twenty-four hours after initial seeding, endothelial sprouts were fixed with 10% paraformaldehyde before sprouting capacity was evaluated by microscopy.
Scratch Wound (Migration) Assay
Transfected human umbilical vein endothelial cells were cultivated in EBM-2 medium at 37°C, 5% CO 2 . The scratches in the cell monolayer were generated with a 100-L tip, and the cells were photographed at 0, 8, and 24 hours with a Zeiss Axiovert 135 microscope. Subsequently, the distance between cell fronts was measured with an AxioVision documentation system (Zeiss).
Proliferation Assays
To measure proliferative capacity in miRNA-modulated cells, a WST-1 (Roche) or standard bromodeoxyuridine proliferation assay (Calbiochem) was applied. MiRNA transfection was performed as mentioned under Transfection Assays. Next, medium was changed and replaced by WST-1 or bromodeoxyuridine reagent as instructed by the manufacturer. WST-1 and bromodeoxyuridine absorbances were measured at 450 and 340 nm, respectively.
Luciferase Reporter Assays
A luciferase reporter assay system was applied to validate potential miRNA targets as described previously. 6 A putative 3ЈUTR miRNA binding sequence was cloned into the SpeI and HindIII cloning site of pMIR-REPORT vector (Ambion). Mutations in the putative miR-24 binding sites were introduced by site-directed mutagenesis (Quick Change II-Site-Directed Mutagenesis Kit; Stratagene). The mutations within the 3ЈUTRs were as follows (8-mer/7mer-8m seed in bold, mutated nucleotides underlined): GATA2 wild-type: 5Ј-CAGGCTGGGCTGAGCCAAAGCCAGAGTG-3Ј, GATA2 mutant 5Ј-CAGGCTGGGCTGGTACAAAGCCAGAGTG-3Ј; PAK4 wild-type 5Ј-CCTCTCCCCCTGAGCCATTGGGGGGGTC-3Ј, PAK4 mutant 5Ј-CCTCTCCCCCTGCTCCATTGGGGGGGTC-3Ј; RASA1 wild-type: 5Ј-TTAACAACCTCTGAGCCTTGGTGTA CAG-3Ј, RASA1mutant5Ј-TTAACAACCTCTGGACCTTGGTGTA CAG-3Ј; H2AFX wild-type (2 sites): 5Ј-CTGGACTGAGCCTC … TG TATGCTATCTGAGCCGTCT-3Ј.
The resulting construct was cotransfected with the miRNAs of interest and a ␤-galactosidase control plasmid (Promega) into HEK293 reporter cells in 48-well plates by use of Lipofectamine 2000 (Invitrogen). A total of 0.2 g of plasmid DNA and 100 nmol/L miRNA was applied. Cells were incubated for 24 hours before luciferase and ␤-galactosidase activity was measured (Promega).
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was used to detect protein-DNA interactions. We applied a ChIP protocol from Weinmann et al 22 with modifications and bioinformatic predictions 23, 24 as detailed in the online-only Data Supplement. The oligonucleotide primer sequences used are given in online-only Data Supplement Table IV .
Viral Transduction
The original green fluorescent protein (GFP)-murine-GATA2 plasmid was a gift from Marjo Simonen (Novartis, Basel, Switzerland). N-terminal GFP-tagged GATA2 was subcloned in an appropriate adenoviral entry vector. Adenoviruses were generated with the Gateway system (Invitrogen) by polymerase chain reaction amplification of the human cDNA sequence and recombination into the pAd/CMV/V5 destination vector (Invitrogen). Subsequently, 15 g of purified recombinant adenoviral DNA was digested with PacI and precipitated with sodium acetate. One microgram of linearized vector was transfected to HEK 293 cells (Invitrogen) with Effectene reagent (Qiagen). After 3 amplifications, adenoviruses were purified and titrated with the Adeno-X Maxi purification kit and rapid titer kit (Clontech). For viral transduction experiments, cells were grown to subconfluence and infected with viral particles for 4 hours before the medium was changed. The multiplicity of infection was 4 to 40. A yellow fluorescent protein control virus was also applied with same multiplicity of infection.
In Vivo Studies
The studies conformed to the Guide for the Care 
Zebrafish Assays
Zebrafish wild-type TU and TL lines and the transgenic line Tg(kdrl:eGFP) s843 were kept at 28.5°C and staged as described previously. 25 To inhibit pigmentation, 0.003% 1-phenyl-2-thiourea was added to the embryo medium. Embryos were injected at the 1-to 2-cell stage with 2 nL of pre-miR-24 (25 mol/L) or control pre-miRs (25 mol/L). Injected embryos were analyzed 48 hours after fertilization (hpf). Images of living embryos were acquired with Leica MZ FLIII or Olympus SZX16 microscopes.
Morpholino-modified oligomers (MOs) were obtained from Gene Tools, LLC (Philomath, OR) and diluted in water containing 0.2% phenol red. Morpholino sequences are listed in online-only Data Supplement Table V . For control purposes, a standard control MO oligomer (MO-control; Gene Tools) was injected at the same concentration as a negative control. One-to 2-cell stage embryos were injected with previously validated 0.2 mmol/L MO1-gata2a 26 or 0.4 mmol/L MO2-gata2a. 27 In the case of pak4, morpholinos were designed against the ATG (MO1-pak4) and the fifth exon/intron boundary (MO2-pak4). One-to 2-cell stage embryos were injected with 2 to 4 ng of MO1-pak4 or 4 to 8 ng of MO2-pak4, respectively. Morpholino knockdown efficiency for start-site-targeting morpholinos was tested as recommended before by an in vivo translationblockage assay. For the splice-site-targeting morpholino, MO2-pak4 knockdown efficiency was tested by RNA isolation from morpholino-injected zebrafish with TRIzol (Invitrogen) and subsequent cDNA from DNase-treated total RNA with M-MLV (Moloney murine leukemia virus) reverse transcriptase (Promega). Primers used for reverse transcriptase polymerase chain reactions are available on request.
For confocal analyses, zebrafish embryos were fixed at 48 hpf in a 4% paraformaldehyde solution overnight and embedded in 1.5% low melting point agarose. Confocal images were obtained with a Leica TCS SP2 confocal laser scanning microscope. The maximum projection algorithm of the Leica software was then used to calculate information sectored in different ranks to a 2-dimensional projection.
Myocardial Infarction
Male mice (C57BL/6, 8 to 10 weeks old) underwent coronary artery ligation for the production of MI as described previously. 28 Cardiac dimensions and function were analyzed by pulse-wave Doppler echocardiography essentially as described previously. 29 Further details are given in the online-only Data Supplement.
Statistical Analysis
Average data are presented as mean and SEM unless otherwise stated. Statistical analysis was performed with the StatView (SAS Institute) package. For statistical comparison of 2 groups, we used an unpaired 2-tailed Student t test; for the comparison of 3 or more groups, we used ANOVA followed by Bonferroni post hoc test. Differences were considered significant when PϽ0.05. In the Figures , probability values are indicated by 1 (PϽ0.05), 2 (PϽ0.01), or 3 (PϽ0.005) asterisks.
Please see the online-only Data Supplement for further details of the methods and materials used.
Results

MiR-24 Is Upregulated in Endothelial Cells by Cardiac Ischemia
A spatiotemporal analysis of miR-24 expression in fractionated cardiac cell types demonstrated selectively strong induction of miR-24 in endothelial cells isolated from ischemic but not remote myocardium early after MI ( Figure 1A ). Accordingly, costaining of mouse cardiac MI sections after in situ hybridization with fluorescein isothiocyanate-conjugated anti-miR-24 probes with cell-type-specific antibodies demonstrated specific enriched endothelial but not smooth muscle cell miR-24 expression in infarcted cardiac areas (Figures 1B and C). The hybridization signal was abolished when a hybridization probe with similar melting temperature but targeted against a scrambled sequence was used (data not shown). In line with the in situ hybridization experiments after ischemic cardiac injury, hypoxic culture conditions increased miR-24 expression in endothelial cells ( Figure 1D ).
MiR-24 Triggers Endothelial Apoptosis and Impairs Angiogenesis
To characterize miR-24 function, we overexpressed synthetic miR-24 precursors in human umbilical vein endothelial cells. MiR-24 overexpression induced apoptosis in endothelial cells, whereas miR-24 antagonism reduced apoptosis ( Figure  2A ). Hypoxia-induced apoptosis of endothelial cells was attenuated by blocking endogenous miR-24, whereas overexpression of miR-24 with synthetic precursors exaggerated endothelial apoptosis ( Figure 2B ). MiR-24 attenuated tube formation (Ϫ81%; PϽ0.0001) independently from its proapoptotic effects, which suggests the potential involvement of multiple target networks ( Figure 2C ; online-only Data Supplement Figure Ia) . Endothelial spheroid formation, sprouting capacity, migration in scratch wound assays, and proliferation were also impaired by miR-24 ( Figures 2C through 2E ).
GATA2 and PAK4 Are Targets of miR-24
To identify miR-24 targets that trigger endothelial apoptosis and impair angiogenic properties, we first used bioinformatics miRNA target prediction tools and detected a substantial number of genes with putative 3ЈUTR binding sites for miR-24 that encompassed important functional roles in en-dothelium (Table 30 -42 ) . Of major interest were the transcription factor GATA2 and the p21-activated kinase PAK4, both of which have established roles in vascular biology. 30, 43, 44 To validate those targets, primary endothelial cells were first transfected with miR-24 precursors. This resulted in repression of GATA2 and PAK4 protein expression. PAK4 was additionally repressed at the mRNA level ( Figure 3A and data not shown). Inhibition of miR-24 in endothelial cells by specific antagonists increased GATA2 and PAK4 expression (data not shown).
When we fused the respective 3ЈUTR regions to a luciferase reporter gene and determined luciferase activity in cells transfected with synthetic miR-24 precursors, miR-24 significantly repressed luciferase activity, whereas unrelated miRNAs showed no effect ( Figure 3B ). We thus identified GATA2 and PAK4 as direct targets of miR-24. Bioinformatic miR-24 target prediction identified further potential targets (Table) . We also validated the RAS p21 protein activator RASA1 and the histone coding gene H2AFX, because of its described role in tumor vascularization. 35 Overexpression of miR-24 in endothelial cells reduced RASA1 and H2AFX protein expression, and luciferase gene reporter assays iden- 
Downstream GATA2 and PAK4 Target Regulation
To understand the observed cellular changes in miR-24 target regulation, we further investigated the downstream signaling cascades of the direct miR-24 targets GATA2 and PAK4. First, we used a global transcriptome analysis after viral overexpression or silencing of GATA2 in endothelial cells The microRNA databases and target prediction tools miRBase (http://microrna.sanger.ac.uk/), PicTar (http://pictar.mdc-berlin.de/), and TargetScan (http:// www.targetscan.org/index.html) were used to identify potential microRNA-24 targets. NA indicates not available. ). Bioinformatics studies identified BAMBI, ESM1, NTN4, heme-oxygenase-1 (HMOX1), and sirtuin-1 (SIRT1) as harboring GATA2 binding sites within their promoter sequence (data not shown). To further validate GATA2-mediated regulation, we used GATA2-ChIP and found those 5 mRNAs to be highly enriched after ChIP ( Figure 4A ). GATA2 overexpression strongly induced protein expression of SIRT1 and HMOX1 (both of which play important roles in angiogenesis 45, 46 ), whereas siRNA-mediated GATA2 silencing reduced expression ( Figure 4B ; online-only Data Supplement Figures IVc and IVd). HMOX1 was regulated by miR-24 via modulation of GATA2 ( Figure 4C ; online-only Data Supplement Figures Va and Vb). HMOX1 exerts vasoprotective and antiapoptotic actions in endothelial cells, 46 and consequently, we found miR-24 -mediated repression of HMOX1 resulted in enhanced reactive oxygen species formation in endothelial cells (online-only Data Supplement Figure Vc) , which may also contribute to recent findings that miR-24 upregulation predisposes cells to DNA damage. 47 To identify proteins that further mediated the proapoptotic action of endothelial miR-24, we hybridized endothelial protein extracts after transfection of scrambled miRs or synthetic miR-24 precursors to a protein microarray spotted with antibodies for proteins involved in apoptosis ( Figure  4D ). A number of proapoptotic proteins were upregulated, eg, HIF-1␣ (HIF-1a) and FAS, although we found a strong reduction of BAD and HMOX1 (Figures 4C through 4E) . The direct miR-24 target PAK4 promotes BAD phosphorylation, thus inactivating the proapoptotic protein BAD. 48 MiR-24 overexpression led to a reduction of phosphorylated BAD (pBAD), whereas miR-24 antagonism increased the pBAD/ BAD ratio ( Figure 4E ). Repression of PAK4 resulted in reduced BAD phosphorylation ( Figure 4F ; online-only Data Supplement Figure IVa) , which contributed to increased apoptosis in endothelial cells ( Figure 3D ). We also blocked miR-24 expression to derepress PAK4, which resulted in enhanced pBAD levels ( Figure 4E ). Knockdown of PAK4 led to reduced pBAD levels in the absence or presence of miR-24 blockade, which suggests that PAK4 is a main modulator of miR-24 -mediated BAD phosphorylation in endothelial cells (online-only Data Supplement Figure VD) .
To test whether the miR-24 targets GATA2, PAK4, and HMOX1 are among the main mediators of the antiangiogenic and proapoptotic action of miR-24 in endothelial cells, we reconstituted those targets in miR-24 -overexpressing endothelial cells. Reconstitution of miR-24 -resistant GATA2, PAK4, and HMOX1 rescued both miR-24 -mediated endothelial apoptosis and miR-24 -impaired tube formation capacity ( Figures 4G and 4H) . We thus identified a network of 
MiR-24 Overexpression and Knockdown of miR-24 Targets Impair Zebrafish Vascular Development
To analyze miR-24 effects in vivo, we first injected miR-24 precursors into Tg(kdrl:eGFP) s843 zebrafish embryos that express GFP in the vasculature. Embryos at 48 hpf had increased miR-24 expression levels ( Figure 5A ), as well as abnormal vessel architecture and insufficient blood transport, which demonstrates that miR-24 activation results in a robust vascular phenotype, although we cannot exclude other celltype-specific effects (Figures 5B through 5I) . To test the involvement of the direct miR-24 targets Gata2 and Pak4 in this model, we used target knockdown experiments. Morpholino-based knockdown of the target gene gata2a ( Figures 5L and 5N) , as well as pak4 (Figures 5P and 5R ; online-only Data Supplement Figure VI) , led to blood accumulation and pericardial edema compared with controls ( Figure 5J ). Furthermore, confocal images of the trunk vasculature revealed impaired vasculature formation. In MO1-gata2a ( Figure 5M ), MO2-gata2a ( Figure 5O ), MO1-pak4 ( Figure 5Q ), and MO2-pak4 ( Figure 5S ) embryos, we observed near-identical phenotypes to the vascularization defects seen in miR-24 -overexpressing zebrafish. MiR-24 -overexpression phenotypes were slightly more severe than single-gene knockdowns (eg, blood accumulation in the trunk was more severe than cranial blood accumulation in pak4 knockdowns; see also online-only Data Supplement Figure  VI D) , which is to be expected given the simultaneous effect of miR-24 on a number of genes.
Therapy With miR-24 Inhibitors Increases Vascularization and Improves Cardiac Function After MI
To further study the effects of miR-24 on vascularization in mammals, we injected chemically engineered cholesterolconjugated single-strand RNA analogues (antagomirs) that targeted miR-24 or scrambled controls into mice. In initial experiments, we found Cy3-labeled antagomirs to be effectively taken up by endothelial cells in vitro ( Figure 6A ). Because we wanted to target mainly the endothelial cell fraction, we first performed titration experiments with Cy3-labeled antagomirs to achieve preferential delivery to endothelial cells. Injection of a Cy3-labeled antagomir at a low dose (5 mg/kg) mainly resulted in cellular uptake in cardiac endothelial cells, whereas injection of a high dose (80 mg/kg) led to a strong homogeneous uptake in all cardiac cells, including cardiomyocytes ( Figure 6B ). Consequently, we found injections of low doses of an antagomir (5 mg/kg, day 0 and day 2) against miR-24 to repress miR-24 but not unrelated miRNAs mainly in fractionated endothelial cells obtained from healthy or ischemic heart tissue (Figures 6B and 6C and data not shown).
We then tested the effects of endothelial miR-24 antagonism in a mouse model of MI. Immunohistochemical studies revealed a greater amount of apoptotic endothelial cells in the periinfarct zone (online-only Data Supplement Figure VII) . In contrast, endothelial apoptosis measured by TUNEL ϩ /PECAM1 ϩ cells was reduced and both capillary and arteriolar density were increased in the periinfarct region after miR-24 antagonism, whereas no changes were observed in the remote myocardium ( Figure 7A ; online-only Data Supplement Figure VII) . Improved capillary density correlated with significant smaller infarct size 14 days after MI (control 54Ϯ6% versus antagomir-24 38Ϯ3%, PϽ0.05).
MI led to an impairment of cardiac function 14 days after intervention ( Figure 7B ). Systolic and diastolic left ventricular diameter and lung wet weight increased after MI ( Figures  7C and 7D ). In contrast, immediate treatment after MI with an antagomir against miR-24 (days 0 and 2) improved cardiac function and attenuated pulmonary congestion and left ventricular dilatation (Figures 7B through 7E ). Baseline data of fractional shortening and left ventricular diameters were not different between the investigated groups (data not shown). Survival of MI animals was significantly improved by miR-24 antagomir treatment (surviving animals at day 14: scrambled antagomir 43.5% versus antagomir-24 78.3%; Pϭ0.02). To exclude significant off-target effects and to confirm specificity of antagomir-24, we injected an antagomir against a scrambled sequence, which did not affect miR-24 expression or infarct healing ( Figures 6C and 7B  through 7E) . A schematic summary of our findings is presented as Figure 7F .
Discussion
In the present study, we identified miR-24 as a critical regulator of endothelial cell survival and angiogenesis. We found miR-24 to be enriched in cardiac endothelial cells and to be upregulated after ischemic injury. However, miR-24 is also expressed in other cells with different cell-specific functions, such as insulin production of pancreatic ␤-cells, in part via regulation of the transcriptional repressor, 49 cell cycle regulation and proliferation of leukemia cells, 50 and activation of smooth muscle cells via repression of Tribbles-like protein 1. 51 In the latter study, long-term hypoxia led to miR-24 upregulation in lung tissue and to activation of lung smooth muscle cells. Thus, inhibition of miR-24 in certain pulmonary diseases may be of future therapeutic relevance. With regard to function in other cardiac cell types, miR-24 
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overexpression has been reported to increase cardiomyocyte hypertrophy in vitro, 52 although a recent study revealed an additional role in cardiomyocyte apoptosis. 53 In that report, 53 the authors described a downregulation of miR-24 in the border zone after MI. In line with those results, we detected a downregulation of miR-24 in fractionated cardiomyocytes early after MI, whereas its expression was massively increased in cardiac endothelial cells. We used post-MI treatment with a low dose of an antagomir (2ϫ5 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ), which silenced miR-24 specifically in endothelial cells but not cardiomyocytes in the heart. Interestingly, high dosing of an antagomir (2ϫ80 mg ⅐ kg Ϫ1 ⅐ d Ϫ1 ) against miR-24 had less favorable effects on cardiac function after MI (data not shown), which suggests potential toxicity of the high-dose group or negative effects on cardiomyocyte biology, as suggested recently. 53 Future studies are therefore needed to develop improved cell-type-specific delivery systems of antagomirs. The role of miR-24 in other ischemic disease conditions and its potential therapeutic value remain to be investigated.
We used bioinformatics analyses to characterize the endothelial miR-24 targetome. So far, we have identified GATA2 (via SIRT1 and HMOX1) and PAK4 (via pBAD) as major miR-24 targets that control a complex network of apoptotic and angiogenic programs in endothelial cells ( Figure 7F ). However, many additional targets may be involved in the action of miR-24, especially in other disease conditions in which target availability may change. Although many other targets might be involved, target reconstitution experiments showed dominant roles of GATA2 and PAK4 for the proapoptotic and antiangiogenic effects of miR-24. The role of other potential targets important for miR-24 biological actions remains to be elucidated.
Importantly, application of low-dose antagomirs permitted silencing of miR-24 expression predominantly in endothelial cells in vivo, which resulted in reduced endothelial apoptosis, enhanced vascularization, decreased infarct size, and improved cardiac function after MI. Thus, miR-24 and its downstream targets may serve as valuable therapeutic entry points to interfere with endothelial genetic programs and thereby improve vascularity and cardiac performance after ischemic injury.
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SUPPLEMENTAL MATERIAL Expanded Methods and Results
Cultivation of cardiovascular cells. Human umbilical vein endothelial cells (HUVECs) were cultured in EGM2 media supplemented with 10% (v/v) fetal calf serum (FCS) and supplements (all reagents from Cambrex Lonza, UK). Cells were grown in a humidified atmosphere at 5% CO 2 and 37°C.
Fractionation of cardiac cell types from heart tissue. The thorax of mice was opened and the aorta was cannulated. After washing with 37°C PBS, the heart together with the cannula was removed and perfused with a collagenase solution for 5 min (Joklik MEM medium supplemented with 10 mM butanedione monoxime, 20 µM calcium chloride, 1mg/ml collagenase II) as described 1 . Then the heart was placed in 37°C pre-warmed collagenase solution for further 25 min and was subsequently divided in infarct and remote areas, minced and filtered through a nylon mesh (200 µm pore size). Then, cardiomyocytes and cardiac fibroblasts were separated by a sedimentation step as described 2 . Within the noncardiomyocyte cell fraction retained in the supernatant an incubation step with CD146-antibodies coupled to microbeads was performed and subjected to magnetic affinity cell sorting according to the manufacturers' recommendations (Mouse CD146 microbead endothelial isolation kit, Miltenyi Biotec, Germany).
Apoptosis protein array.
Apoptosis array data were generated by applying a human apoptosis array kit (ARY009, R&D, USA). 200 µg protein from a pool of three samples were incubated with antibody-coated membranes following manufacturers´ instructions. Various regulated proteins were then validated by Western blotting. Specifically, we searched for targets with known expression in cardiovascular tissue and endothelial cells. We focused on targets predicted by at least two prediction data bases and containing a miR-24-8mer seed match in the respective 3'UTR region.
Detection of reactive oxygen species (ROS)
.
In situ hybridization.
We combined in situ hybridization of miR-24 with endothelial and smooth muscle cell marker stainings. Mouse heart cryosections (10 µm) were dried at room temperature and fixed with 4% PFA for 10 min. at room temperature and washed two times with DEPC-PBS for 3 min.
To increase tissue permeability and reduce unspecific background, the sections were treated with proteinase K (end concentration 5 µg/ ml) for 15 min at 37°C and then were washed two times for 3 minutes with DEPC-PBS. The sections were acetylated 15 minutes at room temperature using acetic anhydride dissolved in DEPC-water, 6N HCl and Triethanolamine and subsequently washed two times with DEPC-PBS for 3 min. Pre-hybridisation was performed 1 hour at 60°C in pre-hybridization buffer containing 50% formamide, 5x SSC, 0. 
